C4 Therapeutics Announces License and Research Collaboration

Initial Focus on One Oncology Target, Exclusive to Collaboration; Merck has Option for Three Additional TargetsWATERTOWN, Mass., Dec. 12, 2023 -- C4 Therapeutics, Inc. , a clinical-stage...

Related Keywords

Canada , George Addona , Courtney Solberg , Andrew Hirsch , Loraine Spreen , Merck Research Laboratories , Corporate Communications Patient Advocacy , Therapeutics Inc , Exchange Commission , Initial Focus , One Oncology Target , Three Additional , Merck Research , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Corporate Communications , Patient Advocacy , Markets ,